| II-040 Yannick Hoffert Model-informed intravenous-to-subcutaneous switching of infliximab in patients with inflammatory bowel diseases Wednesday 15:20-16:50 |
| II-040 Yannick Hoffert Model-informed intravenous-to-subcutaneous switching of infliximab in patients with inflammatory bowel diseases Wednesday 15:20-16:50 |